Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Usability of the Medical Information Device #1 System for schizophrenia.
Multiple locations, including Cerritos
This study is completed in the United States and in Canada. It focuses on Schizophrenia.
Multiple locations, including DothanThis study is active but not recruiting in the United States. It focuses on ADHD.
Multiple locations, including Little RockThis study is completed in the United States, in France, in Canada, .... It is testing intramuscular Formulation of Aripiprazole for Bipolarity.
Multiple locations, including Birmingham
This study is completed in Belgium and in Finland. It is testing Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone for Schizophrenia.
In BelgiumThis study is completed in the United States. It focuses on Schizophrenia.
Multiple locations, including ScottsdaleThis study is completed in the United States. It focuses on Addiction.
Multiple locations, including HamiltonThis study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Los AlamitosThis study is completed in Canada. It focuses on ADHD.
Multiple locations, including CalgaryThis study is completed in the United States. It focuses on Schizophrenia.
In New YorkThis study is completed in the United States. It is testing CLONICEL (Clonidine HCl Sustained Release) for ADHD.
Multiple locations, including Little RockThis study is completed in the United States, in Croatia, and in Latvia. It is testing Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) for schizophrenia.
Multiple locations, including Little RockHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.